These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 2126894)

  • 1. Practice guidelines and professional autonomy in a universal health insurance system: the case of tissue plasminogen activator in Ontario.
    Naylor CD; Hollenberg AA
    Soc Sci Med; 1990; 31(12):1327-36. PubMed ID: 2126894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical guidelines and the fate of medical autonomy in Ontario.
    Rappolt SG
    Soc Sci Med; 1997 Apr; 44(7):977-87. PubMed ID: 9089919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coronary thrombolysis--clinical guidelines and public policy: results of an Ontario practitioner survey.
    Naylor CD; Hollenberg AA; Ugnat AM; Basinski A
    CMAJ; 1990 May; 142(10):1069-76. PubMed ID: 2110859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of economic considerations on clinical decisionmaking: the case of thrombolytic therapy.
    Brody B; Wray N; Bame S; Ashton C; Petersen N; Harward M
    Med Care; 1991 Sep; 29(9):899-910. PubMed ID: 1921539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Creation of the recombinant tissue plasminogen activator (rt-PA) image and its influence on practice habits.
    Sherry S; Marder VJ
    J Am Coll Cardiol; 1991 Nov; 18(6):1579-82. PubMed ID: 1939964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of acute myocardial infarction 1990: a perspective.
    Vogel JH
    Clin Cardiol; 1991 Jan; 14(1):5-9. PubMed ID: 1902150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guidelines for the use of intravenous thrombolytic agents in acute myocardial infarction. Ontario Medical Association Consensus Group on Thrombolytic Therapy.
    Naylor CD; Armstrong PW
    CMAJ; 1989 Jun; 140(11):1289-99. PubMed ID: 2497946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Policy versus practice: comparison of prescribing therapy and durable medical equipment in medical and educational settings.
    Sneed RC; May WL; Stencel C
    Pediatrics; 2004 Nov; 114(5):e612-25. PubMed ID: 15520092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of human resources in health care: the Canadian experience.
    Adams O
    Health Econ; 1992 Jul; 1(2):131-43. PubMed ID: 1341930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost effectiveness of thrombolytic therapy with tissue plasminogen activator as compared with streptokinase for acute myocardial infarction.
    Mark DB; Hlatky MA; Califf RM; Naylor CD; Lee KL; Armstrong PW; Barbash G; White H; Simoons ML; Nelson CL
    N Engl J Med; 1995 May; 332(21):1418-24. PubMed ID: 7723799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medical doctors profile in Ethiopia: production, attrition and retention. In memory of 100-years Ethiopian modern medicine & the new Ethiopian millennium.
    Berhan Y
    Ethiop Med J; 2008 Jan; 46 Suppl 1():1-77. PubMed ID: 18709707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do Legal Issues Deserve Space in Specialty Medical Journals ?
    Nagpal N
    J Assoc Physicians India; 2016 Feb; 64(2):86-87. PubMed ID: 27730795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost, uncertainty, and doctors' decisions. The case of thrombolytic therapy.
    Lessler DS; Avins AL
    Arch Intern Med; 1992 Aug; 152(8):1665-72. PubMed ID: 1497400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medical politics and Canadian Medicare: professional response to the Canada Health Act.
    Stevenson HM; Williams AP; Vayda E
    Milbank Q; 1988; 66(1):65-104. PubMed ID: 3173262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost inflation and resource distribution in the Korean healthcare sector under national insurance.
    Eastaugh SR
    Hosp Top; 1992; 70(4):23-31. PubMed ID: 10122352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rural Alberta thrombolysis study. Survey of practice patterns for managing acute myocardial infarction.
    Hindle H; Norheim JK; Renger R
    Can Fam Physician; 1995 Jul; 41():1180-7. PubMed ID: 7647623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Canada's health care system provides lessons for NPs.
    van der Horst ML
    Nurse Pract; 1992 Aug; 17(8):44, 50-3, 57 passim. PubMed ID: 1501794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential cost effectiveness of intravenous tissue plasminogen activator versus streptokinase for acute myocardial infarction.
    Goel V; Naylor CD
    Can J Cardiol; 1992; 8(1):31-8. PubMed ID: 1617509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. From the History of the Croatian Dermatovenereological Society - The Croatian Medical Association and an Overview of Important Information Regarding the Journal Acta Dermatovenerologica Croatica.
    Dobrić I
    Acta Dermatovenerol Croat; 2018 Dec; 26(4):344-348. PubMed ID: 30665489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The choice of thrombolytic agents in the emergency department.
    Langland-Orban B; Orban DJ
    Ann Emerg Med; 1993 May; 22(5):845-51. PubMed ID: 8470843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.